Fig. 3 | Scientific Reports

Fig. 3

From: Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway

Fig. 3

Effect of rifaximin on liver histopathology. Panel (A), appearance of mice. Panel (B), growth curves of mice. Panel (C), appearance of livers. Panel (D), comparison of liver weight and liver index. Panel (E), comparison of serum ALT level. Panel (F), comparison of H&E staining of livers in each group of mice (scale bar is 20 μm). Panel (G), SAF score. ***P < 0.001, ****P < 0.0001 compared with the CON group. ###P < 0.001, ####P < 0.0001 compared with the MCD group.

Back to article page